Lynch et al. (Lynch et al. 2012) first reported higher O-GlcNAcylation and OGT levels in prostate cancer (PC) tissues and cell lines compared with those in normal samples; they proved that this is related to the invasive phenotype and ability of PC cells and worse clinical outcomes. The gene discussed is OGT; the disease is prostate cancer.